newsfilter
← Latest News
PR Newswire·

Seneca Biopharma Announces Pricing of $5 Million Registered Direct Offering Priced At-the-Market

Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet...